Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%
Lithium
44.60
(0.19%)
Gold
2,668.10
0.23%
Copper
4.21
1.72%
Oil
70.17
2.95%
Bitcoin
95,147.74
(0.74%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,722.51
(0.11%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.11%
Hang Seng
19,746.32
0.82%

Cyclopharm Ltd

CYC

ASX

Cyclopharm is a radiopharmaceutical company servicing the global medical community. The Company's mission is to provide nuclear medicine and other clinicians with the ability to improve patient care outcomes. Cyclopharm achieves this objective primarily through the provision of its core radiopharmaceutical product, Technegas used in functional lung ventilation imaging.

Latest Posts

Line Chart with Gradient
Price
$1.675
0.025 (1.52%)
At Close 02/12 (AEST)
Related Companies
POLYNOVO LIMITED
$PNV
SOMNOMED LIMITED
$SOM
MEDADVISOR LIMITED
$MDR
NANOSONICS LIMITED
$NAN
SONIC HEALTHCARE LIMITED
$SHL

Leave a Comment on CYC


Comments for CYC

    Latest Posts

    cyclopharm-asx-cyc-initiates-pronospect-clinical-trial-in-france-cyc
    Health Care $CYC
    Cyclopharm (ASX: $CYC) initiates PRONOSPECT clinical trial in FranceFirst patients imaged with Technegas, marking a milestone in pulmonary embolism diagnostics
    December 3, 2024
    cyclopharm-asx-cyc-expands-technegas-us-market-reach-cyc
    Health Care $CYC
    Cyclopharm (ASX: $CYC) expands Technegas US market reachTechnegas achieves 82% growth in US opportunities, secures CMS reimbursement, and expands globally
    November 19, 2024
    cyclopharm-asx-cyc-secures-us-government-agreement-for-technegas-supply-cyc
    Health Care $CYC

    Cyclopharm (ASX: $CYC) secures US government agreement for Technegas supply

    Agreement with US Veterans Administration and first Technegas order from US Department of Defense

    October 3, 2024
    cyclopharm-asx-cyc-drives-step-change-in-demand-for-technegas-following-us-reimbursement-cyc
    Health Care $CYC

    Cyclopharm (ASX: $CYC) drives step change in demand for Technegas following US reimbursement

    Successful US reimbursement triggers exponential demand growth and robust revenue from established markets

    September 3, 2024
    cyclopharm-asx-cyc-expands-technegas-applications-beyond-pe-cyc
    Health Care $CYC

    Cyclopharm (ASX: $CYC) expands Technegas applications beyond PE

    USFDA approval for Technegas and expansion into chronic respiratory disease management

    June 20, 2024
    cyclopharm-asx-cyc-secures-pass-through-reimbursement-status-for-technegas-in-the-us-cyc
    Health Care $CYC

    Cyclopharm (ASX: $CYC) secures pass-through reimbursement status for Technegas in the US

    CMS decision to provide full reimbursement for Technegas from July 1, 2024

    June 5, 2024
    cyclopharm-asx-cyc-achieves-milestone-with-first-usa-patients-imaged-with-technegas-cyc
    Health Care $CYC

    Cyclopharm (ASX: $CYC) achieves milestone with first USA patients imaged with technegas

    First USA clinical patients imaged with technegas mark significant progress for Cyclopharm

    March 19, 2024

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) initiates PRONOSPECT clinical trial in France

    First patients imaged with Technegas, marking a milestone in pulmonary embolism diagnostics

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) expands Technegas US market reach

    Technegas achieves 82% growth in US opportunities, secures CMS reimbursement, and expands globally

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) secures US government agreement for Technegas supply

    Agreement with US Veterans Administration and first Technegas order from US Department of Defense

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) drives step change in demand for Technegas following US reimbursement

    Successful US reimbursement triggers exponential demand growth and robust revenue from established markets

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) expands Technegas applications beyond PE

    USFDA approval for Technegas and expansion into chronic respiratory disease management

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) secures pass-through reimbursement status for Technegas in the US

    CMS decision to provide full reimbursement for Technegas from July 1, 2024

    CYC

    $CYC

    Cyclopharm (ASX: $CYC) achieves milestone with first USA patients imaged with technegas

    First USA clinical patients imaged with technegas mark significant progress for Cyclopharm

    Related Companies
    TRIVARX LTD
    $TRI
    EBOS GROUP LIMITED
    $EBO
    IMAGION BIOSYSTEMS LIMITED
    $IBX
    BEAMTREE HOLDINGS LIMITED
    $BMT
    SIGMA HEALTHCARE LIMITED
    $SIG

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions